PROLONGED TREATMENT OF CHRONIC PSEUDOMONAS-AERUGINOSA OSTEOMYELITIS WITH A COMBINATION OF 2 EFFECTIVE ANTIBIOTICS

被引:15
作者
LUCHT, RF
FRESARD, A
BERTHELOT, P
FARIZON, F
AUBERT, G
DORCHE, G
BOUSQUET, G
机构
[1] CHU, HOP BELLEVUE, DEPT ORTHOPAED SURG, F-42055 ST ETIENNE 02, FRANCE
[2] CHU, HOP BELLEVUE, DEPT BACTERIOL, F-42055 ST ETIENNE 02, FRANCE
关键词
D O I
10.1007/BF01739916
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Emergence of Pseudomonas aeruginosa resistant to antibiotic monotherapy is one of the causes of therapeutic failure in chronic P. aeruginosa osteomyelitis. We report 15 cases of chronic (> 3 months of evolution) biopsy culture proven P. aeruginosa osteomyelitis included in an open prospective study evaluating the efficacy of prolonged treatment (> 4 months) with two effective antibiotics in combination. Mean post-treatment follow-up was 38 months. A regimen of cefsulodin in combination with oral ofloxacin was used for six patients, cefsulodin-pefloxacin for three patients, cefsulodin-ciprofloxacin for one patient, piperacillin-pefloxacin for one patient, cefsulodin-fosfomycin for one patient, imipenem-ciprofloxacin for two patients and amoxicillin-ciprofloxacin-fosfomycin for one patient as home therapy. The clinical cure rate of 73% and bacteriological cure rate of 93% are far superior to those previously described in the literature. We did not observe adverse drug reactions. We think that a prolonged use of two effective,antibiotics in combination is a safe and improved therapeutic schedule for chronic P. aeruginosa osteomyelitis.
引用
收藏
页码:276 / 280
页数:5
相关论文
共 21 条
[1]   CEFTAZIDIME AS SINGLE-AGENT THERAPY FOR GRAM-NEGATIVE AEROBIC BACILLARY OSTEOMYELITIS [J].
BACH, MC ;
COCCHETTO, DM .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1987, 31 (10) :1605-1608
[2]   ORAL CIPROFLOXACIN TREATMENT OF PSEUDOMONAS-AERUGINOSA OSTEOMYELITIS [J].
DAN, M ;
SIEGMANIGRA, Y ;
PITLIK, S ;
RAZ, R .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1990, 34 (05) :849-852
[3]   EVALUATION OF PEFLOXACIN, OFLOXACIN AND CIPROFLOXACIN IN THE TREATMENT OF 39 CASES OF CHRONIC OSTEOMYELITIS [J].
DELLAMONICA, P ;
BERNARD, E ;
ETESSE, H ;
GARRAFFO, R ;
DRUGEON, HB .
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 1989, 8 (12) :1024-1030
[4]  
DESPLACES N, 1988, REV INFECT DIS S1, V10, P179
[5]  
ENTROPOULOS GM, 1989, AM J MED S5A, V87, P17
[6]   TREATMENT OF SKIN, SKIN STRUCTURE, BONE, AND JOINT INFECTIONS WITH CEFTAZIDIME [J].
GENTRY, LO .
AMERICAN JOURNAL OF MEDICINE, 1985, 79 (2A) :67-74
[7]   ORAL CIPROFLOXACIN COMPARED WITH PARENTERAL ANTIBIOTICS IN THE TREATMENT OF OSTEOMYELITIS [J].
GENTRY, LO ;
RODRIGUEZ, GG .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1990, 34 (01) :40-43
[8]   EVALUATION OF CIPROFLOXACIN IN THE TREATMENT OF PSEUDOMONAS-AERUGINOSA INFECTIONS [J].
GIAMARELLOU, H ;
GALANAKIS, N ;
DENDRINOS, C ;
STEFANOU, J ;
DAPHNIS, E ;
DAIKOS, GK .
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 1986, 5 (02) :232-235
[9]  
GILBERT DN, 1987, AM J MED, V82, P254
[10]  
GREENBERG RN, 1987, AM J MED, V82, P266